Tech Company Financing Transactions
Luxendo Funding Round
Luxendo, based in San Diego, raised $6 million from EMBL Ventures, Life Sciences Partners and private investors.
Transaction Overview
Company Name
Announced On
10/14/2015
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series A
Investors
EMBL Ventures (Lead Investor) (Stefan Herr)
Life Sciences Partners (Lead Investor) (Joachim Rothe)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 94025
USA
San Diego, CA 94025
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
When compared to conventional microscopy, the SPIM technology allows for significantly reduced sampling times (factor 1000x) and higher resolution with highly reduced damaging side effects on the living objects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Joachim Rothe
Browse more venture capital transactions:
Prev: 10/13/2015: Patara Pharma venture capital transaction
Next: 10/14/2015: Zindigo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs